More tools:Markets·Screener·Research·Chat

Palatin Technologies, Inc. (PTN) Financial Statements

Palatin Technologies, Inc.
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S8HM57
XASE · usd
12.68▼ 0.02 (-0.16%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close12.70
Day's Range11.77 – 13.33
52-Week Range7.21 – 31.00
Volume138.1K
Avg Volume76.6K
Share Statistics
Shares Outstanding
Employees29
ExchangeXASE
Listed1993-11-04
Share count as of May 12, 2026
Loading Income Statement…
Key questions about Palatin Technologies, Inc. (PTN)
What is Palatin Technologies, Inc.'s Market Cap?
Palatin Technologies, Inc.'s Market Cap is $22.6M, based on as-reported figures from SEC (XBRL) filings.
What is Palatin Technologies, Inc.'s Enterprise Value?
Palatin Technologies, Inc.'s Enterprise Value is $12.4M, based on as-reported figures from SEC (XBRL) filings.
What is Palatin Technologies, Inc.'s EV / EBITDA?
Palatin Technologies, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Palatin Technologies, Inc.'s Revenue (TTM)?
Palatin Technologies, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Palatin Technologies, Inc.'s Net Income (TTM)?
Palatin Technologies, Inc.'s Net Income (TTM) is -$6.2M, based on as-reported figures from SEC (XBRL) filings.
What is Palatin Technologies, Inc.'s EBITDA?
Palatin Technologies, Inc.'s EBITDA is -$6.4M, based on as-reported figures from SEC (XBRL) filings.
What is Palatin Technologies, Inc.'s Diluted EPS (TTM)?
Palatin Technologies, Inc.'s Diluted EPS (TTM) is -3.51, based on as-reported figures from SEC (XBRL) filings.
What is Palatin Technologies, Inc.'s Net Debt?
Palatin Technologies, Inc.'s Net Debt is -$10.2M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
REVENUES
Total Revenues——
YoY growth————
OPERATING EXPENSES
Research and Development Expense
Selling, General and Administrative Expense
Gain on sale of Vyleesi————
Gain on purchase commitment———
Total operating expenses
% of revenue140.3%6415.8%——
Loss from operations
% of revenue-40.3%-6315.8%——
OTHER INCOME (EXPENSE)
Non-Operating Income (Expense)
Foreign Currency Gain/Loss——
Interest expense
Total other income (expense), net
NET LOSS
% of revenue-36.5%-6260.0%——
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)